North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Apixaban
found
10 matches
Open monograph to display formulary status
BNF Category
Apixaban
Cardiovascular system - Oral anticoagulants - 02.08.02
Andexanet alfa
(Ondexxya
®
)
Cardiovascular system - Oral anticoagulants - 02.08.02
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
NICE TA245: Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (02.08.02)
NICE TA275: Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (02.08.02)
NICE TA341: Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (02.08.02)
NICE TA697: Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (02.08.02)
